No Data
No Data
Johnson & Johnson Options Trading: A Deep Dive Into Market Sentiment
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report
ACTION Centers Collaborate With Johnson & Johnson MedTech to Secure FDA Labeling for Impella Support System in Pediatric Patients
Market Mixed on Friday the 13th | Livestock
Johnson & Johnson's (NYSE:JNJ) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
RBC Capital Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $181
No Data
Commander93 : no choice. hope next year mid can rebounce back
nzm_mr : at least you get divvy